SCHEMBL115952

SCHEMBL115952

O=CCNc1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5847817 0.98 SMN1; SMN2 (0.41)
SCHEMBL656105 0.80
SCHEMBL11372843 0.77 SMN1; SMN2 (0.40)
SCHEMBL622574 0.76 MEN1 (0.45)
SCHEMBL19728844 0.76 FDPS (0.45)
SCHEMBL6039575 0.73
SCHEMBL4580288 0.73
SCHEMBL970110 0.72
SCHEMBL306157 0.72
SCHEMBL21556963 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114085260-B Steroid derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2023-10-20 CN disclosed
CN-113999277-B Steroid derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2023-08-29 CN disclosed
CN-114085260-A Steroid derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2022-02-25 CN disclosed
US-8450317-B2 CXCR3 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-28 US disclosed
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed
US-20100280028-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 US disclosed
WO-2006038001-A1 AMINOPYRIMIDINE DERIVATIVES AS JNK INHIBITORS CELLTECH R & D LIMITED (GB) 2006-04-13 WO disclosed